Embecta (EMBC) Share-based Compensation Growth (1y) (2021 - 2026)
Embecta (EMBC) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -19.14% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 41.46% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 21.05% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7,260.44% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 47.30% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.08% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -9.05% |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | -211.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.11% |
| Dec 31, 2025 | 59.46% |
| Sep 30, 2025 | 155.56% |
| Jun 30, 2025 | 0.57% |
| Mar 31, 2025 | 119.57% |
| Dec 31, 2024 | -49.32% |
| Sep 30, 2024 | -8,650.00% |
| Jun 30, 2024 | 4,250.00% |
| Mar 31, 2024 | -2,400.00% |
| Dec 31, 2023 | 160.71% |
| Sep 30, 2023 | 101.40% |
| Jun 30, 2023 | -97.20% |
| Mar 31, 2023 | 104.35% |
| Dec 31, 2022 | -39.13% |
| Sep 30, 2022 | -546.88% |
| Jun 30, 2022 | 393.10% |
| Mar 31, 2022 | -258.62% |
| Dec 31, 2021 | 21.05% |